American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
Glucotrack, Inc.
$3.8MMarket cap
$208.0KRevenue · FY2019
-$19.4MNet income
15Employees
GCTKNASDAQ
2000IPO
About Glucotrack, Inc.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Revenue FY2019
- $208.0K
- Net income
- -$19.4M
- Total assets
- $7.8M
- Market cap
- $3.8M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $3.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 10, 2000
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Glucotrack, Inc..
Write a review
Explore
Browse all →
